Literature DB >> 12127959

Ubiquitination of Ro52 autoantigen.

Taeko Fukuda-Kamitani1, Tetsu Kamitani.   

Abstract

Anti-Ro/SSA antibodies are antinuclear antibodies most commonly found in patients with Sjögren's syndrome, a chronic autoimmune disease characterized by dryness of the eyes and mouth. The autoantibodies recognize a RING-finger protein, Ro52/SSA (52 kDa), whose function is still unknown. In this study, the ubiquitination of Ro52 was investigated. We found that Ro52 was strongly conjugated by a single molecule of ubiquitin in cells. Although the biological relevance of this mono-ubiquitination was not defined, the function of Ro52 might be modified by the mono-ubiquitination. We also found that Ro52 was conjugated with poly-ubiquitin chain in cells (poly-ubiquitination), suggesting that Ro52 may be downregulated by the ubiquitin-proteasome pathway in vivo. Interestingly, sera from patients with Sjögren's syndrome showed heterogeneity in their reactivity to poly-ubiquitinated Ro52, probably because of their differing antigenic determinants. This heterogeneity of the reactivity might be associated with the varying clinical features found in patients with Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127959     DOI: 10.1016/s0006-291x(02)00750-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Diagnostic value of trait antinuclear antibodies and multiple immunoglobulin production in autoimmune diseases.

Authors:  Liping Wan; Hong Zhu; Yanan Gu; Hui Liu
Journal:  J Clin Lab Anal       Date:  2017-11-23       Impact factor: 2.352

2.  Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein.

Authors:  Abdelmajid Sabile; Andrea Michael Meyer; Christiane Wirbelauer; Daniel Hess; Ulrike Kogel; Martin Scheffner; Wilhelm Krek
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

3.  HDAC6 regulates antibody-dependent intracellular neutralization of viruses via deacetylation of TRIM21.

Authors:  Songbo Xie; Linlin Zhang; Dan Dong; Ruixin Ge; Qianqian He; Cunxian Fan; Wei Xie; Jun Zhou; Dengwen Li; Min Liu
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

Review 4.  Clinical and pathological roles of Ro/SSA autoantibody system.

Authors:  Ryusuke Yoshimi; Atsuhisa Ueda; Keiko Ozato; Yoshiaki Ishigatsubo
Journal:  Clin Dev Immunol       Date:  2012-12-06

5.  Decreased expression of TRIM21 indicates unfavorable outcome and promotes cell growth in breast cancer.

Authors:  Wenbin Zhou; Yayuan Zhang; Caineng Zhong; Jintao Hu; Hong Hu; Dongxian Zhou; MeiQun Cao
Journal:  Cancer Manag Res       Date:  2018-09-20       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.